Latest News & Updates
Breaking News
4 hours ago
Pharma Now Editorial Team
Bahamas Earns WHO EMTCT Certification, Joining 12 Americas Leaders
Pharma Now Editorial Team
FLAMINGO-01 Interim Data Signals Scale-Up Pressure for GLSI-100
Pharma Now Editorial Team
Oral Semaglutide Eyes Pediatric Label as PIONEER TEENS Hits Primary Endpoint
Pharma Now Editorial Team
Plus Therapeutics Builds Dual-Site GMP Redundancy for REYOBIQ Pivotal Push
Pharma Now Editorial Team
Other trending news you may like to read
WHO 2025 Results: Gains Made, SDG Targets Still at Risk
WHO's 2025 Results Report shows Triple Billion progress but flags funding gaps and missed SDG timelines.
Pharma Now Editorial Team
Bahamas Earns WHO EMTCT Certification, Joining 12 Americas Leaders
The Bahamas achieves WHO EMTCT certification for HIV, meeting transmission rate, pediatric infection, and antenatal coverage thresholds.
Pharma Now Editorial Team
FLAMINGO-01 Interim Data Signals Scale-Up Pressure for GLSI-100
FLAMINGO-01 Phase III interim data shows 70-80% recurrence reduction, raising CMC and scale-up questions for GLSI-100.
Pharma Now Editorial Team
Oral Semaglutide Eyes Pediatric Label as PIONEER TEENS Hits Primary Endpoint
Novo Nordisk's PIONEER TEENS Phase 3a trial meets primary endpoint; pediatric label filings for oral semaglutide planned for H2 2026.
Pharma Now Editorial Team
